The Roy Castle Lung Cancer Foundation launched its new research grant funding scheme.

Awards are provided for pilot grants and project grants, in universities, medical schools/teaching hospitals and research institutes within the UK and Ireland.

Applications are invited in two areas – early detection of lung cancer and patient experience.

The new research grants were officially launched at the 10th annual British Thoracic Oncology Group conference, taking place in Dublin.

Dr David Gilligan, chair of the Roy Castle Lung Cancer Foundation grants committee, said: “Each year around 39,500 people are diagnosed with lung cancer in the UK.

“It is the most common cause of cancer death for both men and women, responsible for nearly a quarters of all male deaths and a fifth of all female deaths.

“Widespread detection of lung cancer, at the point where curative therapy is available, at a ‘pre-cancerous’ stage, would massively impact on survival, which is why we are inviting applications for research projects into high risk population stratification and molecular screening.

“Our second focus is to encourage and foster innovation in patient experience and care. In particular, we invite applications from professional groups such as nurses and allied health professionals, who are actively involved in lung cancer patient experience.

“Our mission is to beat lung cancer by funding innovative, world class research and to make a significant impact on lung cancer for the benefit of all patients.”

Deadline for submissions closes on March 16th 2012.
For more information visit http://www.roycastle.org/researchgrants or call 0151 254 7200 for an application pack.

Source: Roy Castle Lung Cancer Foundation